Welcome to our dedicated page for Newtopia news (Ticker: NEWUF), a resource for investors and traders seeking the latest updates and insights on Newtopia stock.
Newtopia Inc. (NEWUF, TSXV: NEWU) generates news around its tech-enabled whole health platform and personalized habit change programs aimed at preventing, slowing, and reversing chronic and metabolic disease. Company updates often highlight partnerships with large employers, health plans, and regional health initiatives, as well as developments in its GLP-1 companion offerings and strategic corporate actions.
Readers following Newtopia’s news can expect announcements about collaborations with organizations such as Arvest Bank and Heartland Whole Health Institute, framework agreements with supplemental insurance payviders, and expansions of GLP-1 support programs like GLP-1 Ally and GLP-1 Sustain. The company also issues releases on clinical and engagement outcomes from its habit change platform, including results from randomized controlled trials and real-world partnerships.
Newtopia’s news flow includes financing transactions, credit facility arrangements, and updates on its strategic review process, where a Special Committee is evaluating alternatives such as potential corporate sales, mergers, or strategic investments. Regulatory and trading developments, including trading reinstatements, cease trade orders related to financial filing delays, and exchange approvals, are also disclosed through its news releases.
This news page on Stock Titan aggregates these items so investors, analysts, and observers can follow Newtopia’s partnerships, product-related announcements, financial and capital structure developments, and regulatory milestones in one place. For those tracking the intersection of chronic disease prevention, employer health benefits, and GLP-1-related programs, Newtopia’s news provides insight into how the company positions its platform and responds to clinical, economic, and capital market considerations.
Newtopia announced the engagement of Stonegate Capital Partners to enhance its visibility among U.S. investors. The collaboration aims to communicate Newtopia's growth story, primarily driven by its revenue from U.S.-based health insurers. Stonegate will assist in expanding investor relations, starting from a fee of US$5,000 per month. This partnership comes after Newtopia's quotation on the OTCQB Venture Market in August 2021, reflecting the company's strategy to broaden its investor communication.
Newtopia Inc. (TSXV: NEWU, OTCQB: NEWUF) is set to launch an expanded rollout with a Fortune-50 Health Services client in Q1 2022, six months earlier than 2021. This initiative aims to address mental and physical health risks among employees, anticipated to boost welcome kit revenue and recurring subscription fees, driving organic growth. The company reported an 81% engagement rate and an 88% recommendation rate from participants. Newtopia's programs have demonstrated strong outcomes in health improvements, reinforcing its partnership with a major health innovator amid ongoing public health challenges.
Newtopia reported strong Q3 2021 results, with revenues of $2.9 million, up 22% year-over-year and 15% sequentially. Gross profit was $1.4 million, maintaining a gross profit margin of 50%. The company engaged a record 37,000 participants, thanks to a significant rollout with a Fortune 50 client. Adjusted operating loss was $1.0 million, an improvement from $1.4 million last year. Looking ahead, Newtopia expects moderate Q4 revenue but anticipates stronger performance in 2022 driven by expanded business development efforts.
Newtopia Inc. (NEWUF) announced it will release its financial results for Q3 2021 on November 10, 2021, after market close. A conference call will be held at 5:00 p.m. ET to discuss the results in detail. Investors can join the call by dialing U.S. number (877) 407-3982 or International number (201) 493-6780 ten minutes prior to the start time. A replay will be available until November 24, 2021, accessible via U.S. number (844) 512-2921. Newtopia focuses on disease prevention and offers individualized health programs.
Newtopia Inc. (TSXV: NEWU, OTCQB: NEWUF) has increased its credit facility to $7.5 million from a previous $5.0 million, alongside a $2.5 million private placement, totaling $10 million in growth financing. This change is part of an Amending Agreement with a major Canadian bank, aimed at supporting business expansion initiatives. The funds will be allocated to hiring, sales and marketing growth, and advancing habit change technology, enhancing operational efficiencies and customer value. Approval for a 50% guarantee from Export Development Canada is expected shortly.
Newtopia Inc. (TSXV: NEWU, OTCQB: NEWUF), a tech-enabled habit change provider focused on disease prevention, announced participation in the Benzinga Healthcare Conference on September 30, 2021. Jeff Ruby, Founder and CEO, will present at 3:20 PM ET and conduct investor meetings throughout the day. The presentation will be live-streamed on Newtopia's Investor Relations page. Attendees can register for the conference via the Benzinga website. A recent investor presentation is also available online.
Newtopia Inc. will release its financial results for the quarter ended June 30, 2021, on August 12, 2021, after market close. The earnings release will be available on their Investor Relations website and SEDAR. Newtopia focuses on disease prevention through tech-enabled habit changes, targeting chronic diseases like type 2 diabetes and heart disease while promoting mental health. The company aims to reduce healthcare costs for insurers by leveraging individual insights for tailored prevention programs.
Newtopia has appointed Roger Poirier, CFA, to its Board of Directors, expanding its board to five members. With over 30 years in capital markets, finance, and M&A, Poirier will also join the Audit Committee. He founded Whiteshell Group Inc. and co-founded Cormark Securities, bringing significant experience to Newtopia's governance. CEO Jeff Ruby expressed confidence that Poirier's expertise will enhance Newtopia's habit change platform aimed at chronic disease prevention and reducing healthcare costs. The company's innovative approach leverages genetic and behavioral insights to create personalized health programs.
Newtopia Inc. (TSXV: NEWU) launched a revamped investor relations website designed for improved user experience and accessibility across devices. The updated platform enhances transparency and provides essential company information, including press releases and financial data. CEO Jeff Ruby emphasized the site’s role in boosting visibility within the investment community and reflecting Newtopia's identity as an innovative, tech-enabled habit change provider. Additionally, Ruby participated in a podcast, discussing the company’s achievements and strategic growth opportunities.
Newtopia Inc. (TSXV: NEWU) announced the results of a weight loss study on June 22, 2021, revealing significant outcomes during the COVID-19 pandemic. Out of 1,436 participants, 77% lost weight, with an average loss of 4.2%, totaling 35,833 pounds. Notably, 22% of participants dropped a BMI risk category. The study underscores Newtopia's effective habit change platform, which aids health insurers in disease prevention and cost reduction. These results complement previous successful trials and highlight the potential for increased cost savings for employers.